Table 2.
: Summary of main immunological findings in primary headache patients Migraine
Plasma Peripheral blood | Plasma Peripheral blood | Plasma Jugular blood | CSF | |
---|---|---|---|---|
Cytokines/Chemokines/adhesion molecules | Interictal period ∗ | Ictal period∗∗ | Ictal period ∗∗ | Interictal period ∗ |
IL-12 | ↑ | |||
IL-1β | ↑ | ↑↑ | ||
I1L ra | ↑ | |||
TNF-α | ↑ | ↑↑ | ↑ | ↑ |
IFN-γ | ↑ | ↑↑ | ||
IL-2 | = | |||
IL-6 | ↑ | ↑↑ | ||
IL-4 | ↓ | ↓ | ||
IL-5 | ↓ | ↓ | ||
TGF-β | ↑ | ↑ | ||
IL-10 | ↓ | ↑ | ||
IL-8 | ↑ | ↑ | ||
CCL3/MIP-1α | ↑ | ↑ | ||
ICAM-1 | ↑ | |||
Cluster headache | ||||
Plasma Peripheral blood | Plasma Peripheral blood | |||
Cytokines | Interictal period ∗ | Ictal period∗∗ | ||
IL-1β | ↑ | ↑↑ | ||
IL-2 r (soluble) | ↑ § | |||
Tension type headache | ||||
Plasma | CSF | Saliva | ||
Cytokines/Chemokines | Interictal period ∗ | Interictal period ∗ | Interictal period ∗ | |
IL-1β | ↑ | ↑↑ | ||
IL1 ra | ↑ | |||
IL-6 | ↑ | ↑ | ||
TGF-β | ↑ | |||
IL-8 | ↑ | |||
CCL3/MIP-1α | ↑ |
∗vs. control subjects; ∗∗vs. interictal period.
↑increase ↑↑further increase ↓decrease = no changes § active phase.